REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Argomed A.S. (Czech Republic)

Main Activities: Wholesale Trade | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: All Other Support Activities for Transportation | General Warehousing and Storage | Lessors of Real Estate | Lessors of Other Real Estate Property | Custom Computer Programming Services
Full name: Argomed A.S. Profile Updated: October 22, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Argomed A.S. is based in Czech Republic. The head office is in Prague. It operates in the Wholesale Trade industry. It was incorporated on January 12, 2007. From the latest financial highlights, Argomed A.S. reported a net sales revenue increase of 11.47% in 2024. Its total assets grew by 29.93% over the same period. In, 2024, the company’s net profit margin decreased by 2.11%.

Headquarters
Juarezova 1071/17
Prague; The City of Prague; Postal Code: 16000

Contact Details: Purchase the Argomed A.S. report to view the information.

Basic Information
Registered Capital:
Purchase the Argomed A.S. report to view the information.
Financial Auditors:
Purchase the Argomed A.S. report to view the information.
Incorporation Date:
January 12, 2007
Key Executives
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Argomed A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
11.47%▲
Total operating revenue
11.44%▲
Operating profit (EBIT)
-30.08%▼
EBITDA
-30.08%▼
Net Profit (Loss) for the Period
-35.04%▼
Total assets
29.93%▲
Total equity
13.25%▲
Operating Profit Margin (ROS)
-2.26%▼
Net Profit Margin
-2.11%▼
Return on Equity (ROE)
-8.7%▼
Quick Ratio
-0.09%▼
Cash Ratio
0.26%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo